| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 04/14/2005 | CA2544574A1 Stable vitamin b6 derivative |
| 04/14/2005 | CA2541237A1 Modulation of activin to alter inflammatory responses |
| 04/14/2005 | CA2540666A1 Glucocerebroside treatment of disease |
| 04/14/2005 | CA2540638A1 Quinoxaline compounds |
| 04/14/2005 | CA2537769A1 Method to treat the side effects associated with non steroidal anti-inflammatory drugs using microorganisms of the genus bifidobacterium |
| 04/13/2005 | EP1522591A2 Transgenically produced non-secreted proteins |
| 04/13/2005 | EP1522590A1 Methods for producing modified glycoproteins |
| 04/13/2005 | EP1522540A1 Azaarene derivatives |
| 04/13/2005 | EP1522304A2 Compositions containing avenanthramides from extract of oats |
| 04/13/2005 | EP1521824A2 Nucleic acid-associated proteins |
| 04/13/2005 | EP1521822A2 Protein modification and maintenance molecules |
| 04/13/2005 | EP1521779A1 Compounds that bind to the interferon-gamma, preparation method thereof and medicaments containing same |
| 04/13/2005 | EP1521778A1 O-sulphated bacterial polysaccharides and their use |
| 04/13/2005 | EP1521764A2 New compounds, compositions and methods for treatment of inflammatory diseases and conditions |
| 04/13/2005 | EP1521763A2 Novel nonsteroidal anti-inflammatory substances, compositions and methods for their use |
| 04/13/2005 | EP1521757A1 Novel tricyclic spiropiperidines or spiropyrrolidines |
| 04/13/2005 | EP1521744A1 Arylsulphonamide derivatives and use thereof as b1 bradykinin receptor antagonists |
| 04/13/2005 | EP1521740A2 Probucol derivatives |
| 04/13/2005 | EP1521735A2 Single amino acid based compounds for counteracting effects of reactive oxygen species and free radicals |
| 04/13/2005 | EP1521733A1 Modulators of the glucocorticoid receptor |
| 04/13/2005 | EP1521595A1 Novel drug compositions based on novel anticholinergics and inhibitors of egfr-kinase |
| 04/13/2005 | EP1521588A2 Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 04/13/2005 | EP1521580A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and nk1-receptor antagonists |
| 04/13/2005 | EP1521577A1 Methods of using isothiazole derivatives to treat cancer or inflammation |
| 04/13/2005 | EP1521576A1 Novel pharmaceutical compositions comprising novel anticholinergic agents and pde-iv inhibitors |
| 04/13/2005 | EP1521575A1 Aqueous dispersions of nanometric or micrometric particles for encapsulating chemical compounds |
| 04/13/2005 | EP1366050B1 Condensed pyrazindione derivatives as pde inhibitors |
| 04/13/2005 | EP1347986B1 Crystalline glucosamine sulphate metal salts and processes for preparing the same |
| 04/13/2005 | EP1289955B1 Piperidines for use as orexin receptor antagonists |
| 04/13/2005 | EP1257270B1 A method for synthesizing leflunomide |
| 04/13/2005 | EP1212052B1 Therapeutic uses of polymers and oligomers comprising gamma-hydroxybutyrate |
| 04/13/2005 | EP1196136B1 Compositions comprising organosiloxane resins for delivering oral care substances |
| 04/13/2005 | EP1183353B1 Modified chimeric polypeptides with improved pharmacokinetic properties |
| 04/13/2005 | EP1124440B1 Use of calcareous material for foodstuff and cosmetic material |
| 04/13/2005 | EP1105728B1 Modulating multiple lineage kinase proteins |
| 04/13/2005 | EP0975349B1 Serine proteinase inhibitory activity by hydrophobic tetracycline |
| 04/13/2005 | CN1606568A Process for the purification and/or isolation of biologically active granulocyte colony stimulating factor |
| 04/13/2005 | CN1606566A Integrin targeting compounds |
| 04/13/2005 | CN1606563A Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 04/13/2005 | CN1606556A Triazolo-quinolin derivatives useful as adenosine receptor ligands |
| 04/13/2005 | CN1606555A Imidazoquinoline derivatives |
| 04/13/2005 | CN1606554A Beta-lactamyl vasopressin v1aantagonists |
| 04/13/2005 | CN1606545A Pyrrolidine and piperidine derivates as nk1 antagonists |
| 04/13/2005 | CN1606459A 创伤护理装置 Wound care device |
| 04/13/2005 | CN1606457A Methods for sterilizing preparations containing albumin |
| 04/13/2005 | CN1606448A Composition for the treatment of lupus |
| 04/13/2005 | CN1606446A Method for preventing and treating communicable diseases and other diseases using monosaccharides and disaccharides |
| 04/13/2005 | CN1606444A Inhibitors of human phosphatidyl-inositol 3-kinase delta |
| 04/13/2005 | CN1606436A Compounds and methods of treating transplant rejection |
| 04/13/2005 | CN1606427A Stable surfactant compositions for suspending components |
| 04/13/2005 | CN1605353A Liniment for diminishing inflammation and stopping pain and its preparation process |
| 04/13/2005 | CN1605348A Medicinal for treating rheumatism and its preparation |
| 04/13/2005 | CN1196784C Promoter of human endoglin gene and its use |
| 04/13/2005 | CN1196692C Substituted benzopyran derivatives for the treatment of inflammation |
| 04/13/2005 | CN1196687C Inhibitors of IMPDH enzyme |
| 04/13/2005 | CN1196685C Pyrimidine derivatives |
| 04/13/2005 | CN1196682C 4-pyridinyl-N-acyl-L-phenylalanines |
| 04/13/2005 | CN1196681C (+)-Norcisapride useful for 5-HT3 and 5-HT4 mediated disorbers |
| 04/13/2005 | CN1196673C (-)-Verbenzone derivs. |
| 04/13/2005 | CN1196671C Mono-and-disubstituted 2-pyrolyl gamma-aminobutric acids |
| 04/13/2005 | CN1196498C Preparing box for polysaccharide compounding substance |
| 04/13/2005 | CN1196491C Ointment for healing trauumatic injury |
| 04/13/2005 | CN1196481C Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/13/2005 | CN1196479C Use of benzidine prostaglandins of inhalation form |
| 04/13/2005 | CN1196472C Bacterial Chinese medical preparation and preparing method thereof |
| 04/12/2005 | US6878828 Coupling cysteine with benzonitrile, then esterifying, alkylating, hydrolyzing and reacting with acids to form 2-methylcysteine |
| 04/12/2005 | US6878740 Substituted C-furan-2-yl-methylamine and C-thiophen-2-yl-methylamine compounds |
| 04/12/2005 | US6878738 E.g., 2-(2-(4-Chlorophenyl)-6-hydroxymethyl-6-methyl-1-phenyl-6,7- dihydro-5H-pyrrolizin-3-yl)acetic acid; inhibition of 5-lipoxygenase and cyclooxygenase |
| 04/12/2005 | US6878726 For therapy and prophylaxis inflammation, other inflammation associated disorders, such as arthritis, neurodegeneration and colon cancer, in mammals, dogs, cats or livestock animals |
| 04/12/2005 | US6878725 Serine protease inhibitors |
| 04/12/2005 | US6878723 Carbocyclic and/or heterocyclic amino carboxylic acids, e.g., 2-aminomethyl-6-(p-benzylphenoxy)hexanoic acid; leukotriene A4 hydrolase; treating arthritis and psoriasis; hematoprotective and antimitotic agents |
| 04/12/2005 | US6878718 Able to inhibit the binding of integrins to their ligands and are of use in the prophylaxis and treatment of immuno or inflammatory disorders |
| 04/12/2005 | US6878714 Prophylaxis and treatment of angiogenesis mediated diseases such as cancer |
| 04/12/2005 | US6878711 Indole derivatives as PDE5-inhibitors |
| 04/12/2005 | US6878702 Anti-inflammatory agents |
| 04/12/2005 | US6878690 Compounds and methods |
| 04/12/2005 | US6878544 Retinal cell lines with extended life-span and their applications |
| 04/12/2005 | US6878522 Methods for the identification of compounds useful for the treatment of disease states mediated by prostaglandin D2 |
| 04/12/2005 | CA2385854C Formulation for menopausal women |
| 04/12/2005 | CA2203936C Boronic ester and acid compounds, synthesis and uses |
| 04/12/2005 | CA2194471C Bis-piperidinyl non-peptidyl tachykinin receptor antagonist |
| 04/12/2005 | CA2122571C Adhesion receptor antagonists |
| 04/07/2005 | WO2005030975A1 METHOD OF PREPARING α-GLYCOSYLISOQUERCITRIN, INTERMEDIATE THEREFOR, AND BY-PRODUCT |
| 04/07/2005 | WO2005030787A2 Oligonucleotide compositions and methods for treating disease including inflammatory conditions |
| 04/07/2005 | WO2005030773A1 Novel pyrazolopyrimidine derivatives |
| 04/07/2005 | WO2005030771A1 Imidazopyridine-derivatives as inductible no-synthase inhibitors |
| 04/07/2005 | WO2005030770A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | WO2005030769A1 Imidazopyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | WO2005030768A1 Imidazo(4,5-b)pyridine-derivatives as inducible no-synthase inhibitors |
| 04/07/2005 | WO2005030721A1 Piperidine derivative |
| 04/07/2005 | WO2005030235A1 Method of processing ginseng for medicinal use and composition |
| 04/07/2005 | WO2005030214A1 HEXA- AND OCTAHYDRO-PYRIDO[1,2-a]PYRAZINE DERIVATIVES WITH NK1 ANTAGONISTIC ACTIVITY |
| 04/07/2005 | WO2005030212A1 4-aminoquinoline-3-carboxamide derivatives as pde4 inhibitors |
| 04/07/2005 | WO2005030124A2 Antibodies to m-csf |
| 04/07/2005 | WO2005016918A3 Heterocyclic n-aryl carboxamides as cytokine inhibitors |
| 04/07/2005 | WO2005012351A8 Novel functions for decay accelerating factor (daf) in inflammation |
| 04/07/2005 | WO2005012269A8 Novel azole compound |
| 04/07/2005 | WO2004096206A3 Therapeutic combination of a cox-2 inhibitor and a tace inhibitor |
| 04/07/2005 | WO2004014871A8 Vanilloid receptor ligands and their use in treatments |
| 04/07/2005 | WO2004006847A3 Selected antibodies and duramycin peptides binding to anionic phospholipids and aminophospholipids and their use in treating viral infections and cancer |